John Overdeck Two Sigma Investments
John Overdeck is a co-founder of Two Sigma Investments, one of the world’s leading quantitative and technology-driven investment firms. Two Sigma applies data science, machine learning, and large-scale computing to markets across asset classes. Overdeck’s firm is a central reference point in discussions of modern systematic investing.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Intel
INTC
|
+$267M |
| 2 |
Amazon
AMZN
|
+$243M |
| 3 |
Applied Materials
AMAT
|
+$242M |
| 4 |
Airbnb
ABNB
|
+$221M |
| 5 |
Meta Platforms (Facebook)
META
|
+$213M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Micron Technology
MU
|
+$262M |
| 2 |
Bristol-Myers Squibb
BMY
|
+$259M |
| 3 |
Wells Fargo
WFC
|
+$238M |
| 4 |
Broadcom
AVGO
|
+$233M |
| 5 |
Applovin
APP
|
+$225M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 15.95% |
| 2 | Healthcare | 13.56% |
| 3 | Financials | 11.46% |
| 4 | Consumer Discretionary | 9.22% |
| 5 | Industrials | 9.1% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
626
Brixmor Property Group
BRX
$9.03B
| $12.3M | 0.03% |
441,218
+376,995
| +587% | +$10.7M |
|
|
GOGL
627
DELISTED
Golden Ocean Group
GOGL
| $12.3M | 0.03% |
1,369,826
-430,615
| -24% | -$4.64M |
|
628
Dave Inc
DAVE
$4.6B
| $12.2M | 0.03% |
140,670
+117,960
| +519% | +$7.9M |
|
629
HCI Group
HCI
$2.3B
| $12.2M | 0.03% |
104,754
-15,856
| -13% | -$1.81M |
|
630
Morningstar
MORN
$8.16B
| $12.2M | 0.03% |
+36,237
| New | +$12.4M |
|
631
AXIS Capital
AXS
$7.27B
| $12.2M | 0.03% |
137,582
-15,438
| -10% | -$1.32M |
|
632
JPMorgan BetaBuilders US Equity ETF
BBUS
$9.13B
| $12.2M | 0.03% |
+114,900
| New | +$12.2M |
|
633
PennantPark Floating Rate Capital
PFLT
$736M
| $12.1M | 0.03% |
1,106,128
-248,248
| -18% | -$2.78M |
|
634
Travere Therapeutics
TVTX
$6.17B
| $12.1M | 0.03% |
693,016
+332,933
| +92% | +$5.89M |
|
635
Apogee Therapeutics
APGE
$10.2B
| $12.1M | 0.03% |
266,482
+67,174
| +34% | +$3.43M |
|
636
CRISPR Therapeutics
CRSP
$5.51B
| $12.1M | 0.03% |
306,272
+127,219
| +71% | +$6.01M |
|
637
Vermilion Energy
VET
$1.9B
| $12M | 0.03% |
1,281,074
+6,765
| +0.5% | +$65.9K |
|
638
Qorvo
QRVO
$8.39B
| $12M | 0.03% |
172,157
-129,832
| -43% | -$10.4M |
|
639
Westlake Corp
WLK
$9.76B
| $12M | 0.03% |
104,320
-37,289
| -26% | -$4.85M |
|
640
Schneider National
SNDR
$6.04B
| $11.9M | 0.03% |
407,375
+129,332
| +47% | +$3.85M |
|
|
ITCI
641
DELISTED
Intra-Cellular Therapies Inc.
ITCI
| $11.9M | 0.03% |
142,791
+119,301
| +508% | +$9.8M |
|
642
Mercado Libre
MELI
$100B
| $11.8M | 0.03% |
6,953
-98,938
| -93% | -$193M |
|
643
Halozyme
HALO
$12.2B
| $11.8M | 0.03% |
247,030
+197,918
| +403% | +$10.1M |
|
|
CWAN
644
DELISTED
Clearwater Analytics
CWAN
| $11.8M | 0.03% |
429,139
+407,485
| +1,882% | +$11.6M |
|
645
Credit Acceptance
CACC
$6.23B
| $11.8M | 0.03% |
25,144
+14,355
| +133% | +$6.66M |
|
|
TIGR
646
UP Fintech Holding
TIGR
$922M
| $11.7M | 0.03% |
1,817,787
+1,617,702
| +809% | +$11.1M |
|
647
GeneDx Holdings
WGS
$2.54B
| $11.7M | 0.03% |
152,073
+111,657
| +276% | +$7.8M |
|
648
Vanguard Morningstar Mega Cap ETF
MGC
$10.2B
| $11.7M | 0.03% |
+54,800
| New | +$11.6M |
|
|
NEE.PRS
649
NextEra Energy 7.299% Corporate Units
NEE.PRS
$2.09B
| $11.7M | 0.03% |
238,846
-1,312,641
| -85% | -$68.6M |
|
650
Corebridge Financial
CRBG
$14.2B
| $11.6M | 0.03% |
387,891
-436,500
| -53% | -$13.5M |
|
Similar funds
John Overdeck's Q4 2024 Portfolio in Review
As of Q4 2024, John Overdeck held 3,590 positions worth $45.9B, up 0.48% from $45.6B the previous quarter. Its ten largest holdings account for 7.2% of the portfolio.
John Overdeck withdrew a net $1.69B in Q4 2024, closing 427 positions and reducing 1,388 holdings. Its most notable exit was iShares MSCI Emerging Markets ETF, an estimated $184M position sold in full.
By sector, the portfolio is most concentrated in Technology at 16% of assets, down from 18% a quarter earlier, followed by Healthcare and Financials.
Against the trend, John Overdeck opened a new position in Intel worth $237M.
- John Overdeck's largest Q4 2024 buy was Intel: 11,843,258 shares worth $237M.
- John Overdeck added most to Amazon in Q4 2024, an estimated $243M increase.
- John Overdeck's biggest Q4 2024 reduction was Micron Technology, cutting an estimated $262M.
- John Overdeck fully exited iShares MSCI Emerging Markets ETF in Q4 2024, selling an estimated $184M.
- John Overdeck's ten largest holdings make up 7.2% of its $45.9B portfolio in Q4 2024.
- John Overdeck opened 477 new positions and closed 427 in Q4 2024.
- John Overdeck's portfolio value rose 0.48% quarter-over-quarter to $45.9B.
Based on Two Sigma Investments's 13F filing for Q4 2024, filed 14 Feb 2025.